Isct
Membership Organizations · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
744 W Hastings St Ste 325, Vancouver, Br...Phone Number
(604) 874-4366Website
www.isctglobal.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Isct
The International Society for Cell & Gene Therapy (ISCT) is dedicated to advancing cell and gene therapies to enhance patient outcomes. They offer a range of services including annual and regional meetings, educational resources, and publications such as the Cytotherapy journal. ISCT aims to support professionals in the field through workforce development and regulatory initiatives. Their intended clients include researchers, healthcare providers, and industry professionals involved in cell and gene therapy.Explore more
Isct Org Chart
AB
President, Past-, Chair Strategic Advisory Co...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Isct your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Isct is spiking on competitors!
Click to see if Isct had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Isct launches new products
Check if Isct has recently received funding, and reach out quickly before it becomes old news!
Isct, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Isct
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Isct has new funding data
Earning: See what the market has to say on Isct recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Isct
Compare insights from companies similar to Isct, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Isct
<$5M
11-50
Private
-
1992
JG
Jacques GalipeauPresident, Immediate & Chair, Strategic Advisory Council
Company Profile Activity
Activity Insights
Isct is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Isct is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Isct.
Isct Tech Stack
A closer look at the technologies used by Isct
See more technologies
Isct News & Media
Elucidate Bio Announces Joint Poster Presentation with IN8bio at ISCT 2026
Joint ISCT 2026 poster highlights spatial multi-omic analysis of GBM patients treated with γδ T cell therapy, revealing tumor microenvironment insights. MEDFORD, MA, UNITED STATES, May 6, 2026 /EINPresswire.com/ -- Elucidate Bio, Inc., an AI-enabled …Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”) today presents its most recent clinical data from its lead dual-targeting chimeric antigen receptor T-cell (“CAR-T”) therapy product candidate, TPST-2003, at the International Society for Cell & Gene Therapy (“ISCT”) Scientific Annual Meeting in Dublin, Ireland. Updates include the latest data from the ongoing REDEEM-1 Phase 1/2a trial evaluating TPST-2003, as well as progress in Tempest’s otBioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
Data demonstrate progress in each of its MSC-derived programsFactor Bioscience to Showcase Engineered iMacrophages (FACT-112) Targeting Ovarian Cancer In Vivo at ISCT 2026
- Factor to reveal latest pre-clinical data on FACT-112: engineered iMacrophages for treating solid-tumors CAMBRIDGE, Mass., April 30, 2026 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop...
Read more news
Top Membership Organizations Companies
Frequently Asked Questions Regarding Isct
Sign Up For FreeTo access detailed company insights
The International Society for Cell & Gene Therapy (ISCT) is dedicated to advancing cell and gene therapies to enhance patient outcomes. They offer a range of services including annual and regional meetings, educational resources, and publications such as the Cytotherapy journal. ISCT aims to support professionals in the field through workforce deve... Read More
